Skip to main content
Premium Trial:

Request an Annual Quote

10x Genomics Acquires Denmark's Tetramer Shop

NEW YORK – 10x Genomics announced Wednesday that it has acquired Copenhagen, Denmark-based T cell detection startup Tetramer Shop.

"Tetramer Shop's expertise in building empty, loadable major histocompatibility complex (MHC) molecules accelerates the development of T cell receptor-based therapeutics and diagnostics, broadening 10x Genomics immunology efforts," the firm said in a statement. Financial and other terms of the deal were not disclosed.

Launched in 2019, Tetramer Shop is a spinout from Danish Technical University and is based on technology originally developed at Jacobs University in Bremen, Germany.

Tetramer Shop Cofounder Søren Jakobsen will lead a 10x facility in Copenhagen while Cofounders Sine Hadrup, Sunil Kumar, and Sebastian Springer will become advisors to 10x Genomics.

In July 2020, Tetramer Shop announced a strategic partnership with China's Polaris Biology to commercialize metal-labelled MHC tetramers for distribution in China.

The acquisition is 10x's fifth, following 2018 deals for Epinomics and Spatial Transcriptomics and last year's purchases of in situ analysis startups ReadCoor and Cartana, for $350 million and $41.5 million, respectively.

In Thursday morning trading on the Nasdaq, shares of 10x Genomics were flat at $179.63.

The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports.

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.